Dr Maria Jelinic & Hericka Figueiredo Galvao (Co-Chairs)

The Cardiovascular SIG (formed in 2008) aims to foster collaboration and exchange of ideas across all areas of cardiovascular research.

Dr Nicholas Farinola (Chair) & Dr Chris Cameron (Deputy Chair)

Clinical Pharmacology involves all aspects of safe, effective and rational use of medicines in humans (individual, group, or population levels).

Dr Emma van der Westhuizen (Chair) & Dr Simon Foster (Deputy Chair)

This forum provides an opportunity for the exchange of ideas and sharing of issues of concern. Please use it to ask questions, highlight initiatives or events, or propose ideas for future Forum events.

Dr Cornelia Landersdorfer & Dr David Shackleford (Co-Chairs)

Drug Disposition and Response involves the distribution, metabolism and excretion of drug and the relationship between drug concentrations and effects.

Assoc Professor Kellie Charles (Chair) & Assoc Professor Tina Hinton (Immediate Past Chair)

A conduit for the sharing of ideas and resources between those involved in pharmacology education, with the overall aim of ensuring that all students of pharmacology receive a quality education that prepares them for their future careers.

Dr Nicholas Hunt (Chair)

The Innovation and Industry SIG is open to all experimental through to clinical pharmacologists and toxicologists, as well as those from industry in its broadest sense, who have an interest and/or role in moving innovations along the pathway towards generating medical products or services to benefit patients. Including and engaging with industry, from biotech start-ups through to large pharma, is critical to the success of these endeavours.

Dr Eryn Werry & Dr Celine Valant (Co-Chairs)

The Neuro- & Behavioural Pharmacology SIG aims to promote Neuro- and Behavioural Pharmacology research both within ASCEPT and the greater scientific community including similarly aligned societies such as APS and ANS. There is a depth of high quality, internationally competitive Neuro- & Behavioural Pharmacology research within Australia and this SIG provides a forum for researchers and teachers to communicate, forge collaborations and further advance this field. This is a vital asset to support and encourage young investigators in their career development thereby nurturing our future leaders in Neuro- & Behavioural Pharmacology. ASCEPT provides an ideal platform to promote and advance the study of Neuro- & Behavioural Pharmacology and this endeavour promotes mutual benefit to ASCEPT and researchers alike.

Dr Katie Burns (Chair)

To provide an annual forum to promote and disseminate pharmacology & toxicology research, clinical practice and education within New Zealand and beyond.

ASCEPT NZ Forum Committee:
Dr Katie Burns (Chair), A/Prof Matt Doogue (Secretary), Dr Jacqui Hannam (Treasurer), Prof Michelle Glass (member), and Dr Jack Flanagan (Committee Member), A/Prof Hesh Al-Sallami (Committee Member).

Dr Edwin Tan (Chair) & Mr George Tan (Deputy Chair)

The role of the Pharmacoepidemiology SIG is to promote and support pharmacoepidemiological research and collaboration within ASCEPT members.

Dr Sophie Stocker (Chair) & Dr Nuala Helsby (Deputy Chair)

The Pharmacogenomics SIG addresses molecular mechanisms, clinical impact and public health implications of genomics affecting drug response and adverse effects.

Dr Chantal Donovan (Chair) & Dr Paris Papagianis (Deputy Chair)

The Respiratory & Inflammation SIG aims to facilitate cutting edge research in the areas of respiratory and inflammatory diseases.

Miss Aisling McEvoy (Chair)

Professor Garth Maker (Chair) & Dr Slade Matthews (Deputy Chair)

Open to all who have an interest in toxicology. Including but not limited to drugs, medicines and consumer product toxicity, pesticides and agrichemicals, nanomaterials, occupational chemicals and industrial pollutants, naturally occurring toxic chemicals and poisons, poisoning management and clinical toxicity.

Professor Helen Irving & Dr Sab Ventura (Co-Chairs)

The Urogenital/Gastrointestinal SIG promotes research in the field of urogenital and gastrointestinal pharmacology and disseminate findings to Australian researchers while encouraging early career researchers with opportunities to present their work.